Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Dropped head syndrome: report of three cases during treatment with a MEK inhibitor.

Chen X, Schwartz GK, DeAngelis LM, Kaley T, Carvajal RD.

Neurology. 2012 Oct 30;79(18):1929-31. doi: 10.1212/WNL.0b013e318271f87e. Epub 2012 Oct 17. No abstract available.

2.

MEK 1/2 inhibitors in the treatment of hepatocellular carcinoma.

Facciorusso A, Licinio R, Carr BI, Di Leo A, Barone M.

Expert Rev Gastroenterol Hepatol. 2015 Jul;9(7):993-1003. doi: 10.1586/17474124.2015.1040763. Epub 2015 Apr 27. Review.

PMID:
25915713
3.

The clinical development of MEK inhibitors.

Zhao Y, Adjei AA.

Nat Rev Clin Oncol. 2014 Jul;11(7):385-400. doi: 10.1038/nrclinonc.2014.83. Epub 2014 May 20. Review.

PMID:
24840079
4.

MEK1/2 inhibitors in the treatment of gynecologic malignancies.

Miller CR, Oliver KE, Farley JH.

Gynecol Oncol. 2014 Apr;133(1):128-37. doi: 10.1016/j.ygyno.2014.01.008. Epub 2014 Jan 14. Review.

PMID:
24434059
5.

Controversies in the management of advanced melanoma: "gray" areas amid the "black and blue".

Jarkowski A 3rd, Norris L, Trinh VA.

Ann Pharmacother. 2014 Nov;48(11):1456-68. doi: 10.1177/1060028014544165. Epub 2014 Jul 23. Review.

PMID:
25056920
6.

From basic research to clinical development of MEK1/2 inhibitors for cancer therapy.

Frémin C, Meloche S.

J Hematol Oncol. 2010 Feb 11;3:8. doi: 10.1186/1756-8722-3-8. Review.

7.

[New treatment options for metastatic melanoma].

Tietze JK, Berking C.

Dtsch Med Wochenschr. 2014 Jul;139(28-29):1462-7. doi: 10.1055/s-0034-1370155. Epub 2014 Jul 1. Review. German. No abstract available.

PMID:
24983194
8.

Future of combination therapy with dabrafenib and trametinib in metastatic melanoma.

Zia Y, Chen L, Daud A.

Expert Opin Pharmacother. 2015;16(14):2257-63. doi: 10.1517/14656566.2015.1085509. Epub 2015 Sep 2. Review.

PMID:
26331795
9.

The role of MEK inhibitors in the treatment of metastatic melanoma.

Grimaldi AM, Simeone E, Ascierto PA.

Curr Opin Oncol. 2014 Mar;26(2):196-203. doi: 10.1097/CCO.0000000000000050. Review.

PMID:
24419498
10.

Trametinib in metastatic melanoma.

Chopra N, Nathan PD.

Expert Rev Anticancer Ther. 2015;15(7):749-60. doi: 10.1586/14737140.2015.1060127. Review.

PMID:
26107021

Supplemental Content

Support Center